Preventive effects of pioglitazone and its mechanisms in the non-obese diabetic mouse

( views:102, downloads:0 )
SUN Shu-guang()
ZHOU Zhi-guang()
ZHANG Song()
Journal Title:
Volume 15, Issue 04, 2007
Key Word:


  • [1]Leiter EH.The NOD mouse:a model for insulin-dependent diabetes mellitus.Cur Prot Immunol,1997,s24:15.9.1-15.9.23.
  • [2]Augstein P,Dunger A,Heinke P,et al.Prevention of autoim mune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells.Biochem Biophys Res Commun,2003,304:378-384.
  • [3]裴剑浩,周智广,罗建华,等.吡格列酮对非肥胖性糖尿病小鼠糖尿病的预防作用及机理探讨.中华医学杂志,2004,84:411-415.
  • [4]罗建华,周智广,蒋铁建,等.人谷氨酸脱羧酶65DNA疫苗预防非肥胖糖尿病小鼠糖尿病的机制探讨.中华医学杂志,2004,84:46-51.
  • [5]Abdelrahman M,Sivarajah A,Thiemermann C.Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury,inflammation and shock.Cardiovasc Res,2005,65:772-781.
  • [6]Diep QN,El Mabrouk M,Cohn JS,et al.Structure,endothelial function,cell growth,and inflammation in blood vessels of an giotensin Ⅱ-infused rats:role of peroxisome proliferator-activated receptor-γ.Circulation,2002,105:2296-2302.
  • [7]Natarajan C,Bright JJ.Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyeli tis by blocking IL-12 production,IL-12 signaling and Thl differentiation.Gene Immun,2002,3:58-70.
  • [8]Saubermann LJ,Nakajima A,Wada K,et al.Peroxisome proliferator-activated receptor-gamma agonist ligands stimulate a Th2cytokine response and prevent acute colitis.Inflamm Bowel Dis,2002,8:330-339.
  • [9]Wang P,Anderson PO,Chen S,et al.Inhibition of the tran scription factor AP-1 and NF-kappaB in CD4+T cell by Peroxisome proliferator-activated receptor-gamma ligands.Int Immunopharmacol,2001,1:803-812.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615